ShareSpot: Rifampin Drug-Drug Interactions with Newer Antiretrovirals

ShareSpot: Rifampin Drug-Drug Interactions with Newer Antiretrovirals

Friday, May 11, 2018
TARGET Center

From the AETC NCRC - This issue of AETC ShareSpot discuss drug interactions between rifampin (used in tuberculosis treatment) and a some newer antiretrovirals and how these interactions have the potential to hinder antiretroviral therapy (ART). Three studies from CROI 2018 are summarized for the antiretroviral medications Tenofovir alafenamide, Bictegravir, and Dolutegravir.

This summary is by Dr. Jennifer Cocohoba, Health Sciences Associate Clinical Professor in the Department of Clinical Pharmacy at the UCSF School of Pharmacy.